Up next

Autoplay

Clinical Trial: Darzalex (daratumamab) with Revlimid/Velcade/Dex for Newly Diagnosed Myeloma

1 Views • 08/29/25
Share
Side Effects
Side Effects
Subscribers
0

Peter Voorhees, MD of the Levine Cancer Institute shares a clinical trial for newly diagnosed myeloma patients using Darzalex (daratumumab), Revlimid, Velcade and dexamethasone before transplant, then adding dara into consolidation and maintenance post transplant. For more clinical trials, go to https://www.healthtree.org/

Show more
0 Comments sort Sort By

Up next

Autoplay